Search
Search Results
-
Real-World Sarilumab Use and Rule Testing to Predict Treatment Response in Patients with Rheumatoid Arthritis: Findings from the RISE Registry
IntroductionClinical trial findings may not be generalizable to routine practice. This study evaluated sarilumab effectiveness in patients with...
-
Rheumatoid factor and falsely elevated results in commercial immunoassays: data from an early arthritis cohort
The aim of the study was to assess RF cross-reactivity to animal antibodies used in immunoassays, and to test if selected commercial immunoassays...
-
Necrotizing autoimmune myositis following coronavirus disease 2019 infection: a case report
BackgroundSevere acute respiratory syndrome coronavirus 2 may be associated with late-onset necrotizing myositis, mimicking autoimmune inflammatory...
-
Multifocal leukoencephalopathy in a patient medicated with etanercept and methotrexate for rheumatoid arthritis
Methotrexate (MTX) and etanercept are commonly used in the treatment of rheumatoid arthritis (RA). Several important adverse events, including...
-
Incidence and predictors of fragility fracture in postmenopausal rheumatoid arthritis patients receiving oral bisphosphonates: a longitudinal observational study
BackgroundAlthough many studies have reported the predictors of fractures in patients with rheumatoid arthritis (RA) who are not receiving...
-
Functional respiratory impairment and related factors in patients with interstitial pneumonia with autoimmune features (IPAF): Multicenter study from NEREA registry
BackgroundThe objective of the present study is to describe the characteristics of interstitial pneumonia with autoimmune features (IPAF) patients,...
-
Role of interleukin-35 in rheumatoid arthritis pathogenesis and its relation to disease activity and joint damage
AimThis study aimed to discuss the role of interleukin-35 (IL-35) in the pathogenesis of rheumatoid arthritis (RA) and its relation to disease...
-
Diabetes mellitus in rheumatic diseases: clinical characteristics and treatment considerations
New pathophysiological insights are now available on comorbidities in rheumatic diseases (RDs). Several nationwide studies point to the fact that...
-
Poor glycemic control enhances the disease activity in the RA patients with undiagnosed diabetes—a cross-sectional clinical study
BackgroundRheumatoid arthritis (RA), an autoimmune disorder, characterized by systemic inflammation and swollen joints, establishes itself as a...
-
Micro RNA-23b as a potential biomarker in rheumatoid arthritis disease activity and severity: clinical, laboratory, and radiological cross-sectional study
BackgroundRheumatoid arthritis (RA) is an autoimmune inflammatory disease. It is characterized by an inflammatory polyarthritis that preferentially...
-
Long-term Efficacy and Safety Following Switch Between Upadacitinib and Adalimumab in Patients with Rheumatoid Arthritis: 5-Year Data from SELECT-COMPARE
IntroductionThis study aimed to describe the long-term efficacy and safety of upadacitinib and adalimumab through 228 weeks following immediate...
-
Deciphering the different phases of preclinical inflammatory bowel disease
Inflammatory bowel disease (IBD) is an immune-mediated inflammatory disease (IMID) of the gastrointestinal tract and includes two subtypes: Crohn’s...
-
Serum and synovial matrix metalloproteinases 1 and 3 in patients with early rheumatoid arthritis: potentially prospective biomarkers of ultrasonographic joint damage and disease activity
BackgroundMatrix metalloproteinase-1 (MMP-1) and MMP-3 play important roles in the pathogenesis of rheumatoid arthritis (RA) and have been suggested...
-
Bone marrow findings in rheumatoid arthritis patients with peripheral cytopenias
ObjectiveThe aim was to study bone marrow (BM) cellularity, morphological characteristics, and types of cellular infiltrates in rheumatoid arthritis...